Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 3 I, 1996, Pages 713-719

  Zissel, Gernot ^c   Homolka, Jiri ^a   Schlaak, Jörg ^c   Schlaak, Max ^c   Müller Quernheim, Joachim ^b  

^a Alexander von Humboldt Stiftung   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; DISEASE ACTIVITY; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LUNG SARCOIDOSIS; PRIORITY JOURNAL; REMISSION;

EID: 0029796362     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.3.8810610     Document Type: Article

References (36)

1. Müller-Quernheim, J., S. Pfeiffer, D. Männel, J. Strausz, and R. Ferlinz. 1992. Lung restricted activation of the alveolar macrophage/ monocyte system in pulmonary sarcoidosis. Am. Rev. Respir. Dis. 145:187-192.
2. Müller-Quernheim, J., C. Saltini, P. Sondermeyer, and R. G. Crystal. 1986. Compartmentalized activation of the interleukin-2 gene by lung T-lymphocytes in active pulmonary sarcoidosis. J. Immunol. 137: 3475-3483.
3. Wahl, S. M., N. McCartney-Francis, and S. Mergenhagen. 1989. Inflammatory and immunoregulatory roles of TGF-β. Immunol. Today 10:258-261.
4. Khalil, N., R. N. O'Connor, H. W. Unruh, P. W. Warren, K. C. Flanders, A. Kemp, O. H. Bereznay, and A. H. Greenberg. 1991. Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic fibrosis. Am. J. Respir. Cell Mol. Biol. 5:155-162.
5. Denis, M., and E. Ghadirian. 1992. Transforming growth factor-beta is generated in the course of hypersensitivity pneumonitis: contribution to collagen synthesis. Am. J. Respir. Cell Mol. Biol. 7:156-160.
6. 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 149:197-204.
7. Roth, M., and S. Golub. 1993. Human pulmonary macrophages utilize prostaglandins and transforming growth factor beta 1 to suppress lymphocyte activation. J. Leukocyte Biol. 53:366-371.
8. Bogdan, C., J. Paik, Y. Vodovotz, and C. Nathan. 1992. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J. Biol. Chem. 267: 23301-23308.
9. Khalil, N., O. H. Bereznay, M. B. Sporn, and A. H. Greenberg. 1989. Macrophage production of transforming growth factor-β and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 170:727-737.
10. 1 during lymphocyte activation. J. Immunol. 145:1415-1422.
11. deWaal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209-1220.
12. Taga, K., and G. Tosato. 1992. Il-10 inhibits human T cell proliferation and Il-2 production. J. Immunol. 148:1143-1148.
13. Street, N. E., and T. R. Mosmann. 1991. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 5:171-177.
14. Hunninghake, G. W., O. Kawanami, V. J. Ferrans, R. C. Young, W. C. Roberts, and R. G. Crystal. 1981. Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am. Rev. Respir. Dis. 123:407-412.
15. Hunninghake, G. W., and R. G. Crystal. 1981. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N. Engl. J. Med. 305:429-434.
16. Bøyum, A. 1983. Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium. Scand. J. Immunol. 17:429-436.
17. Ikeda, T., M. N. Lioubin, and H. Marquardt. 1987. Human transforming growth factor type beta 2: production by a prostatic adenocarcinoma cell line, purification, and initial characterization. Biochemistry 26:2406-2410.
18. Schlaak, J., E. Schmitt, C. Hüls, K. H. Meyer zum Büschenfelde, and B. Fleischer. 1994. A sensitive and specific bioassay for the detection of human IL-10. J. Immunol. Methods 168:49-54.
19. Gillis, S., M. M. Ferm, W. Ou, and K. A. Smith. 1978. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027-2032.
20. Ahuja, S. S., F. Palliogianni, H. Yamada, J. E. Balow, and D. Boumpas. 1993. Effect of transforming growth factor-β on early and late activation events in human T cells. J. Immunol. 150:3109-3118.
21. Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163: 1037-1050.
22. Wahl, S. M., D. A. Hunt, L. M. Wakefield, N. McCartney-Francis, L. M. Wahl, A. B. Roberts, and M. B. Sporn. 1987. Transforming growth factor (TGF-beta) induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. U.S.A. 84:5788-5792.
23. 1 gene results in multifocal inflammatory disease. Nature 359:693-699.
24. 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U.S.A. 90:770-774.
25. Robinson, B. W. S., T. McLemore, and R. G. Crystal. 1985. Gamma interferon is spontaneously released by alveolar macrophages and lung T-lymphocytes in patients with pulmonary sarcoidosis. J. Clin. Invest. 75:1488-1495.
26. + T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur. J. Immunol. 24: 793-798.
27. Hance, A. J., S. Douches, R. J. Winchester, V. J. Ferrans, and R. G. Crystal. 1985. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis. J. Immunol. 134:284-292.
28. Nelson, B., D. Danielpour, J. L. Rossio, J. Turpin, and C. A. Nacy. 1994. Interleukin-2 suppresses activated macrophage intracellular killing activity by inducing macrophages to secrete TGFβ. J. Leukocyte Biol. 55:81-90.
29. Giri, S. N., D. M. Hyde, and M. A. Hollinger. 1993. Effect of antibody to transforming growth factor-β on bleomycin induced accumulation of lung collagen in mice. Thorax 48:959-966.
30. Kelley, J. 1993. Transforming growth factor-β. In J. Kelley, editor. Cytokines of the Lung. Marcel Dekker, New York, Basel, Hong Kong. 101-137.
31. Silver, I. A., R. J. Murrills, and D. J. Etherington. 1988. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp. Cell Res. 175:266-276.
32. McCartney-Francis, N. L., and S. M. Wahl. 1994. Transforming growth factor β: a matter of life and death. J. Leukocyte Biol. 55:401-409.
33. Yamauchi, K., Y. Martinet, P. Basset, G. A. Fells, and R. G. Crystal. 1988. High levels of transforming growth factor-β are present in the epithelial lining fluid of the normal human lower respiratory tract. Am. Rev. Respir. Dis. 137:1360-1363.
34. Baecher-Allan, C. M., and R. K. Barth. 1993. PCR analysis of cytokine induction profiles associates with mouse strain variation in susceptibility to pulmonary fibrosis. Regul. Immunol. 5:207-217.
35. Bonner, J. C., A. Badgett, P. M. Lindroos, and A. R. Osornio-Vargas. 1995. Transforming growth factor β1 downregulates the platelet-derived growth factor α-receptor subtype on human lung fibroblasts in vitro. Am. J. Respir. Cell Mol. Biol. 13:496-505.
36. Ayanlar Batuman, O., A. P. Ferrero, A. Diaz, and S. A. Jimenez. 1991. Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. J. Clin. Invest. 88: 1574-1580.